Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Ohhara N is active.

Publication


Featured researches published by Ohhara N.


Infection and Immunity | 1989

Protective effect of recombinant murine granulocyte-macrophage colony-stimulating factor against Pseudomonas aeruginosa infection in leukocytopenic mice.

Takeshi Tanaka; Seiichi Okamura; K. Okada; A. Suga; N. Shimono; Ohhara N; Yuichi Hirota; Y. Sawae; Yoshiyuki Niho

The effects of recombinant murine granulocyte-macrophage colony-stimulating factor (rmGM-CSF) against Pseudomonas aeruginosa infection in ICR mice were investigated. Mice were treated with cyclophosphamide (CPA) and were then injected intraperitoneally with rmGM-CSF three times daily, beginning on the day after CPA treatment, for 7 days. The number of peripheral blood leukocytes in both CPA- and rmGM-CSF-treated mice and control CPA-treated mice reached a nadir on day 4, when P. aeruginosa was injected intraperitoneally. The administration of rmGM-CSF significantly increased the proportion of survivors among mice infected with a lethal dose of P. aeruginosa. This effect was further analyzed by monitoring sequential changes in leukocyte count and bacterial growth in various organs. The number of bacteria in the peritoneal cavities, peripheral blood samples, and livers of GM-CSF-treated mice decreased to an undetectable level after a transient increase, and the number was significantly lower than that in control mice. In GM-CSF-treated mice, the neutrophil levels in peripheral blood started to increase 5 days after CPA administration and were consistently higher than those in controls. Furthermore, the neutrophils in GM-CSF-treated mice were more mature morphologically. Thus, the prophylactic effect of rmGM-CSF against P. aeruginosa infection may result from a rapid recovery of myelopoiesis and a partial enhancement of mature neutrophil function.


International Journal of Immunopharmacology | 1988

Stimulatory effects of bestatin on human B-cell colony formation

Teruhisa Otsuka; Seiichi Okamura; Ohhara N; Mine Harada; Shin Hayashi; Shigeru Yamaga; Fusayuki Omori; Yoshiyuki Niho

Bestatin, (2S, 3R)-3-amino-2-hydroxy-4-phenylbutyryl-L-leucine, is a small molecular immunomodifier. Effects of this compound on human immune function were studied, in vitro, using the human B-cell colony formation technique. B-cell colonies were obtained from enriched B-cell populations placed in conditioned methylcellulose medium containing stimulators and irradiated T-cells as feeders. Addition to the culture of Bestatin at concentrations of 0.1 microgram/ml and 1 microgram/ml led to a significant increase (P less than 0.05) in the number of B-cell colonies and this effect was abolished when irradiated T-cells were not added to the culture. Bestatin increased soluble factor production induced by phytohemagglutinin (PHA)-stimulated T-cells. Such findings suggest that T-cells probably mediate this stimulatory effect of Bestatin on B-cell colony formation.


Leukemia Research | 1987

Treatment of four patients with myelodysplastic syndrome with a small dose of aclacinomycin-A☆

Tsunefumi Shibuya; Eiji Morioka; Shuichi Taniguchi; Ohhara N; Seiichi Okamura; Yoshiyuki Niho

The effect of a small dose of aclacinomycin-A (ACR) was examined in two patients with refractory anemia (RA) and two with refractory anemia with excess of blasts in transformation (RAEB-t). ACR (7 or 14 mg/m2) was given for 10 days in a 2-h per day drip infusion. Clinical symptoms and laboratory data improved in 3 of these 4 patients. In a patient with RA, marked increase in reticulocytes and elevation of the hemoglobin level from 6 to 9 g/dl was observed after two courses of ACR therapy. In two with RAEB-t, Auers rod bearing cells disappeared in the bone marrow and megaloblastic change of the erythroblasts was diminished in one patient. Hemoglobin levels rose from 4.7 to 10 g/dl in one, and platelets and WBC increased in another. No effect was seen in a patient with RA. The cytoreductive effect of ACR was minor compared to the therapy with small dose of cytosine arabinoside (Ara-C). Therefore, ACR warrants further consideration for the treatment of patients with MDS.


Research in Experimental Medicine | 1988

Granulocyte-macrophage colony formation in vitro using human non-phagocytic bone marrow cells

Ohhara N; Seiichi Okamura; Shin Hayashi; Teruhisa Otsuka; Yoshiyuki Niho

SummaryA technique employing silica particles was used to remove cells producing endogenous colony-stimulating factor (CSF) to allow measurement of the level of colony-forming units in culture (CFU-C) in human bone marrow cells. In comparison with the glass-adherence technique, this new approach resulted in a more complete degree of removal of CSF-producing cells and formation of more colonies. This method seems to be useful for performing an accurate assay of exogenous CSF.


Research in Experimental Medicine | 1990

Methylcholanthrene-induced murine fibrosarcoma cell line BMT-11 secretes granulocyte colony-stimulating factor

Ohhara N; Seiichi Okamura; Shin Hayashi; Tsunefumi Shibuya; F. Okada; Makoto Ishikawa; Masao Hosokawa; Hiroshi Kobayashi; Yoshiyuki Niho

SummaryMurine fibrosarcoma cell line BMT-11 was induced with 3-methyl-cholanthrene and maintained in culture. Transplantation of BMT-11 into syngeneic C57 BL/6 mice produced leukocytosis consisting of marked increments of neutrophils and monocytes associated with massive splenomegaly. In order to elucidate the mechanisms of this leukemoid reaction, we studied the changes occurring in hematopoietic progenitor cells in BMT-11-transplanted mice. The numbers of granulocyte-macrophage colony-forming units (CFU-GM), erythroid colony-forming units (CFU-E), erythroid burst-forming units (BFU-E), and mixed colony-forming units (CFU-Mix) in the spleen showed dramatic 216-fold, 18-fold, 64-fold, and 80-fold increases, respectively, relative to the value in the control mice 5 weeks after the BMT-11 implantation. In contrast, the levels of progenitor cells in the bone marrow remained within normal limits. The nature of the colony-stimulating factor (CSF) secreted from BMT-11 tumor cells was also studied. BMT-11-conditioned medium (BMT-11-CM), BMT-11 tumor extract, and sera from the mice bearing transplanted BMT-11 tumor contained CSF that stimulated mainly granulocyte and macrophage lineages. Furthermore, the expression of the granulocyte colony-stimulating factor (G-CSF) gene in BMT-11 cells were detected by Northern blot analysis.


Journal of the National Cancer Institute | 1987

Marked Granulocytosis in C57BL/6 Mice Bearing a Transplanted BMT-11 Fibrosarcoma

Makoto Ishikawa; Masuo Hosokawa; Ohhara N; Yoshiyuki Niho; Hiroshi Kobayashi


The Journal of Rheumatology | 1988

Multipotent hemopoietic progenitor cells in patients with systemic lupus erythematosus.

Teruhisa Otsuka; Seiichi Okamura; Mine Harada; Ohhara N; Shin Hayashi; Shigeru Yamaga; Kohei Nagasawa; Yoshiyuki Niho


Japanese Journal of Cancer Research | 1987

Human bladder carcinoma cell line HTB9, which secretes a factor to stimulate clonogenic leukemic blast growth, expresses the granulocyte-macrophage colony-stimulating factor gene.

Shin Hayashi; Seiichi Okamura; Yoshinobu Asano; Ohhara N; Teruhisa Otsuka; Tsunefumi Shibuya; Yoshiyuki Niho


Japanese Journal of Medicine | 1987

Aplastic anemia associated with type A viral hepatitis--possible role of T-lymphocytes.

Kunihiko Aoyagi; Ohhara N; Seiichi Okamura; Teruhisa Otsuka; Tsunefumi Shibuya; Yujiro Yamano; Yasuo Tsuda; Yoshiyuki Niho


Research communications in chemical pathology and pharmacology | 1990

Direct action of human granulocyte colony-stimulating factor on mature human neutrophils: flow-cytometric analysis.

Kondo S; Seiichi Okamura; Ohhara N; Yoshiyuki Niho

Collaboration


Dive into the Ohhara N's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge